Navigation Links
Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology

relate these promising in vitro data."

Steven Porter, CEO of Ceragenix stated: "The publication of peer-reviewed research on our Ceragenin(TM) compounds is an important milestone for our Company and a key element in obtaining recognition for our technology in the scientific community. We look forward to future publications from our ongoing preclinical research activities on the safety and efficacy work that is now being conducted in vivo."

About Ceragenix

Ceragenix Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops and commercializes novel anti-infective drugs based on its proprietary class of compounds, Ceragenins(TM) (or CSAs). Active against a broad range of gram positive and negative bacteria, these agents are being developed as anti-infective medical device coatings (Ceracides(TM)) and as therapeutics for antibiotic-resistant organisms. Ceragenix also owns exclusive rights to Barrier Repair Technology for the treatment of dermatological disorders including atopic dermatitis, neonatal skin disorders and others. Ceragenix's patented Barrier Repair Technology, invented by Dr. Peter Elias and licensed from the University of California, is the platform for the development of two prescription topical creams--EpiCeram(TM) and NeoCeram(TM). For additional information on Ceragenix, please visit www.ceragenix.com.

FORWARD LOOKING STATEMENTS

This press release may contain forward-looking statements. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including, but not limited to, the following: the ability of the company to raise sufficient capital to finance its planned activities; the ability of the company to satisfy its outstanding convertible debt obligations; receiving the necessary marketing clearance approvals from the United States Food and Drug Administration; suc
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
2. Ceragenix Announces Results from Phase IV Study of EpiCeram Meet All Primary and Secondary Endpoints
3. Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm Formation in 21 Day Study
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General ... AMGN ) announced today that they ... and validate new therapeutic targets and develop novel ... disorder that affects millions worldwide. The MGH-Broad-Amgen collaboration ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and ... be able to protect their most important business ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of the ... steadfastly remains one of the most litigious industry ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2
... CHARLOTTESVILLE, Va. , May 28 The Focused Ultrasound Surgery ... the 2nd International Symposium on MR-guided Focused Ultrasound and can be accessed ... , , ... near Dulles International Airport, Washington, DC , the symposium ...
... ProUroCare Medical, Inc. (OTC Bulletin Board: PUMD, PUMDU and PUMDW), ... will be attending the American Urological Association (AUA) 2010 Annual ... – June 1 . At the conference, the ... to educate urologists about the concept and potential of elasticity ...
Cached Medicine Technology:Abstract Submissions and Registration Now Open for 2nd International Symposium on MR-Guided Focused Ultrasound 2Abstract Submissions and Registration Now Open for 2nd International Symposium on MR-Guided Focused Ultrasound 3ProUroCare to Showcase Investigational Portable Platform for Its Prostate Imaging Device at AUA 2010 2
(Date:4/17/2014)... non-cancerous prostate tissue may have nearly twice the risk ... inflammation, according to results of a new study led ... , The link between persistent inflammation and cancer was ... those with a Gleason score between 7 and ... and rapidly growing prostate cancers. , "What we,ve shown ...
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... 2014) Doctors who treat patients with a ... can face an agonizing treatment decision. , The ... and help relieve shortness of breath. But some ... can cause potentially fatal complications following transplantation. , ... Dilling, medical director of Loyola University Medical Center,s ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... - Avoid Select Vitamins, Try Acupuncture, NORTHBROOK, ... American College of Chest Physicians (ACCP) recommend,against the ... general,screening of lung cancer. Published as a supplement ... of the ACCP, the guidelines cite there,is little ...
... Ohio, Sept. 10 AtriCure, Inc.,(Nasdaq: ATRC ... and selling innovative cardiac surgical devices, announced,today that ... implanted during an open-heart surgical procedure performed by,Professor ... University of Zurich,in Switzerland with the support of ...
... think they have a vaginal yeast infection are wrong ... treating their problem, says a Saint Louis University researcher ... isnt a yeast infection, said Susan Hoffstetter, Ph.D., assistant ... Louis University School of Medicine and a SLUCare womens ...
... Sept. 10 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) ... officer, will provide an update on,the progress of Sangamo,s ... business strategy at 1:30 pm (PT) on Monday,September 17, ... San Francisco. The presentation will be webcast live ...
... A vascular surgery technique pioneered at UT Southwestern ... thigh to repair the aorta does not create blood-flow ... patients, researchers report. , Vascular disease is a major ... of the aorta. Inserting synthetic grafts to repair damaged ...
... could fight cancer, heart disease, researchers say , , MONDAY, Sept. ... life, a new European study suggests. , "The intake ... from any cause of death," said lead researcher Dr. Philippe ... Lyon, France. , The new finding, published in the Sept. ...
Cached Medicine News:Health News:New Lung Cancer Guidelines Oppose General CT Screening 2Health News:New Lung Cancer Guidelines Oppose General CT Screening 3Health News:New Lung Cancer Guidelines Oppose General CT Screening 4Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 2Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 3Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 4Health News:Common misdiagnosis: most women believe they have a yeast infection when they don't 2Health News:Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference 2Health News:Natural aorta grafts have few side effects for infection-prone patients 2Health News:Vitamin D Supplements May Lengthen Life 2
Fechtner Trabeculectomy Marker...
... Accurately tests for Nystagmus when rotated ... high by 8" diameter. Light weight ... bearings for effortless spin mechanism. For ... patient. Includes both Adult and Pediatric ...
Sterile squares of smooth foil for repair of the floor of the orbit and other plastic surgery. Available in large size....
Segment stand magnifiers come complete with bar magnifier to achieve a higher magnification while still maintaining a wide binocular field of view....
Medicine Products: